Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Conference Presentations
, 2014, 'Adalimumab and Infliximab levels in neonates correlate with duration of treatment in pregnancy (ERA study)', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000231&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Prospective single-blinded single-centre randomized controlled trial in comparing Moviprep, a polyethylene glycol-based solution with PrepKit C, a combined polyethylene glycol and sodium picosulfate-based solution in the preparation of patients for colonoscopy', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000267&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Thiopurine prescribing and monitoring behaviour, including metabolites testing and allopurinol co-therapy: an Australian perspective from 2008 to 2013', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000224&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Third party funding for Fecal Calprotectin is likely to reduce colonoscopy usage in Australia: Gastroenterologists' use and knowledge of its role in clinical practice', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000213&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Conference Abstracts
, 2026, 'ASSOCIATION BETWEEN INFLAMMATORY BOWEL DISEASE AND HIDRADENITIS SUPPURATIVA: AN INTERNATIONAL MULTICENTER RETROSPECTIVE STUDY', in GASTROINTESTINAL ENDOSCOPY, MOSBY-ELSEVIER, IL, Chicago, Vol. 103, pp. S1012 - S1013, presented at Digestive Disease Week (DDW), IL, Chicago, 02 May 2026 - 05 May 2026
, 2026, 'COLECTOMY TRENDS IN ULCERATIVE COLITIS AMIDST AN EXPANDING THERAPEUTIC LANDSCAPE: INSIGHTS FROM A CLINICAL CARE REGISTRY', in GASTROINTESTINAL ENDOSCOPY, MOSBY-ELSEVIER, IL, Chicago, Vol. 103, pp. S1334 - S1335, presented at Digestive Disease Week (DDW), IL, Chicago, 02 May 2026 - 05 May 2026
, 2026, 'DOP088 IBD-PERFECT: Development of a performance evaluation and review framework to improve clinical care in Inflammatory Bowel Disease', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.125, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.125
, 2026, 'N06 Exploring predictors associated with Inflammatory Bowel Disease (IBD) helpline (HL) utilisation in a regression model: Crohn’s Colitis Cure Data Insights Program', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.1538, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.1538
, 2026, 'P0454 Automated versus clinician-entered phenotyping of inflammatory bowel disease using an Australasian multicentre real-world database: Crohn’s Colitis Cure Data Insights Program', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.635, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.635
, 2026, 'P0507 Ulcerative proctitis: Limited extent but an underestimated burden – insights from the Crohn’s Colitis Cure Data Insights Program', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.688, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.688
, 2026, 'P0578 Second-line adalimumab is a viable therapeutic option after infliximab failure in perianal Crohn’s disease: a real-world study', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.759, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.759
, 2026, 'P0583 Building a consumer co-care mobile app – Methodology & consumer insights', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.764, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.764
, 2026, 'P0623 Prescribing patterns and persistence of advanced therapies in people with Ulcerative Colitis who are bio-experienced: Insights from the Crohn’s Colitis Care (CCCare) registry', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.804, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.804
, 2026, 'P0633 Prescribing Patterns and Persistence of Advanced Therapies in people with Crohn’s disease with prior advanced therapy: Crohn’s Colitis Cure Data Insights Program', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.814, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.814
, 2026, 'P0665 Influenza vaccination uptake in a real-world Australasian Inflammatory Bowel Disease cohort: Crohn’s Colitis Cure (CCC) data insight’s program', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.846, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.846
, 2026, 'P06705-year Inflammatory Bowel Disease nursing helpline trends in a real-world Australasian cohort: Crohn’s Colitis Cure data insight’s program', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.851, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.851
, 2026, 'P0736 Skin cancer surveillance uptake in a real-world Australasian Inflammatory Bowel Disease Cohort: Crohn’s Colitis Cure (CCC) data insight’s program', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.917, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.917
, 2026, 'P0811 The likely return on investment from broad implementation of an Inflammatory Bowel Disease-specific clinical quality registry – towards sustainable Inflammatory Bowel Disease care', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.992, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.992
, 2026, 'P0911 Real-world trends in subcutaneous and intravenous infliximab and vedolizumab use in Inflammatory Bowel Disease from 2021 to 2024: Insights from Crohn’s Colitis Cure Data Insights Program', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.1092, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.1092
, 2026, 'P1115 Scoping the digital desert in Australian/New Zealand IBD care - A review of consumer available IBD-related mobile apps', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.1296, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.1296
, 2026, 'P1216 Measuring what matters in Inflammatory Bowel Disease: Early results from the IBD-PERFECT initiative', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.1397, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.1397
, 2026, 'P1239 Divided by distance: Insights into regional disparities in Inflammatory Bowel Disease care across Australia from the Crohn’s Colitis Care Registry', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.1420, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.1420
, 2026, 'P1254 CCCare: A clinician-led, people-centric model for scalable data-driven Improvement in Inflammatory Bowel Disease care', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.1435, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.1435
, 2026, 'P1262 Longitudinal trends in benchmarking performance in Inflammatory Bowel Disease care amongst Australasian centres: A real-world registry study from the Crohn’s Colitis Cure Data Insights Program', in Journal of Crohn's and Colitis, Oxford University Press (OUP), Vol. 20, pp. jjaf231.1443, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.1443
, 2026, 'Colectomy trends in Ulcerative Colitis amidst an expanding therapeutic landscape: Insights from a clinical care registry', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 20, http://dx.doi.org/10.1093/ecco-jcc/jjaf231.843
, 2025, 'ACTIVE PERIANAL FISTULISING CROHN'S DISEASE IS ASSOCIATED WITH A HIGHER BURDEN OF PSYCHOLOGICAL DISTRESS, DEPRESSION, ANXIETY, STRESS AND OPIOID USE', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, Vol. 169, presented at Digestive Disease Week, CA, San Diego, 03 May 2025 - 06 May 2025
, 2025, 'CONSISTENCY AND QUALITY OF INFLAMMATORY BOWEL DISEASE CARE IN AUSTRALASIA; TOWARDS BENCHMARKING.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, Vol. 169, presented at Digestive Disease Week, CA, San Diego, 03 May 2025 - 06 May 2025
, 2025, 'CORRELATION OF BIOCHEMICAL, ENDOSCOPIC AND HISTOLOGIC ENDPOINTS IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS: A POST-HOC ANALYSIS FROM THE VIEWS RANDOMISED CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, Vol. 169, presented at Digestive Disease Week, CA, San Diego, 03 May 2025 - 06 May 2025
, 2025, 'CORTICOSTERIOD AND OPIATE USE IN INFLAMMATORY BOWEL DISEASE, 25 YEARS AFTER THE CROHN'S THERAPY, RESOURCE, EVALUATION, AND ASSESSMENT TOOL (TREAT) WAS ESTABLISHED', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, Vol. 169, presented at Digestive Disease Week, CA, San Diego, 03 May 2025 - 06 May 2025
, 2025, 'EXTENSIVE DISEASE CLEARANCE AS A NOVEL COMPOSITE ENDPOINT TO PREDICT LONG-TERM RELAPSE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS: A POST-HOC ANALYSIS FROM THE VIEWS RANDOMISED CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, Vol. 169, presented at Digestive Disease Week, CA, San Diego, 03 May 2025 - 06 May 2025
, 2025, 'GUT MICROBIOTA CHANGES ARE ASSOCIATED WITH TYPE OF ADVANCED THERAPY IN PATIENTS WITH IBD: BASELINE DATA FROM THE AUSTRALIAN IBD MICROBIOME STUDY', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, Vol. 169, presented at Digestive Disease Week, CA, San Diego, 03 May 2025 - 06 May 2025
, 2025, 'IMPAIRED HEALTH-RELATED QUALITY OF LIFE IS ASSOCIATED WITH ALTERATIONS IN GUT MICROBIOTA SIGNATURES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: BASELINE DATA FROM THE AUSTRALIAN IBD MICROBIOME STUDY', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, Vol. 169, presented at Digestive Disease Week, CA, San Diego, 03 May 2025 - 06 May 2025
, 2025, 'IRON DEFICIENCY, WITH OR WITHOUT ANAEMIA, IN INFLAMMATORY BOWEL DISEASE REMAINS AN UNDERMANAGED ISSUE: CROHN'S COLITIS CURE DATA INSIGHTS PROGRAM', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, Vol. 169, presented at Digestive Disease Week, CA, San Diego, 03 May 2025 - 06 May 2025
, 2025, 'THE IBD LIFE QUESTIONNAIRE: WORLD-WIDE DEVELOPMENT AND VALIDATION AND INTERCONTINENTAL DIFFERENCES OF NORMAL LIFE IMPAIRMENT', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, Vol. 169, presented at Digestive Disease Week, CA, San Diego, 03 May 2025 - 06 May 2025
, 2024, 'Microbial signatures associated with inflammatory bowel disease in Australia: baseline sequencing from the Australian IBD Microbiome study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 39, pp. 216 - 217
, 2023, 'Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 17, pp. 542 - 542, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000960367601125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care', in Intestinal Research, Vol. 20, pp. 506 - 508, http://dx.doi.org/10.5217/ir.2022.00003
, 2022, 'IDDF2022-ABS-0162 Histological remission using a nancy index of 0 is associated with longer relapse-free survival than histological activity in patients with ulcerative colitis in clinical and endoscopic remission', BMJ, pp. a149.2 - a1a149, presented at Clinical Gastroenterology, http://dx.doi.org/10.1136/gutjnl-2022-iddf.207
, 2022, 'Synchronous gastric and colon metastasis as an initial presentation of breast cancer: A case report', in Pathology, Elsevier BV, Vol. 54, pp. S45 - S45, http://dx.doi.org/10.1016/j.pathol.2021.12.146
, 2021, 'USING A CONSENSUS-BASED METHOD TO DEVELOP A NOVEL PAEDIATRIC-SPECIFIC INFLAMMATORY BOWEL DISEASE EHEALTH CLINICAL MANAGEMENT SYSTEM', in GUT, BMJ PUBLISHING GROUP, HONG KONG, Hong Kong, Vol. 70, pp. A108 - A109, presented at International Digestive Disease Forum (IDDF), HONG KONG, Hong Kong, 04 September 2021 - 05 September 2021, http://dx.doi.org/10.1136/gutjnl-2021-IDDF.127
, 2021, 'Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease', in Jgh Open, Vol. 5, pp. 1063 - 1070, http://dx.doi.org/10.1002/jgh3.12631
, 2021, 'Designing a national education program to support quality use of medicines for patients with inflammatory bowel disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 36, pp. 122 - 122, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800193&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Identifying the top 10 research priorities of people living with inflammatory bowel disease, their carers, and health care professionals in Australia', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 36, pp. 116 - 116, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800184&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Patient satisfaction with the inflammatory bowel disease specialist telephone consultation', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 36, pp. 107 - 107, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Using a consensus-based method to develop a novel pediatric-specific inflammatory bowel disease eHealth clinical management system', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 36, pp. 165 - 166, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Validity of stomal calprotectin measurement in assessing Crohn's disease activity', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 36, pp. 125 - 125, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'Clostridium difficile infection in patients with inflammatory bowel disease: An Australian experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 146 - 146, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200212&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'Higher anti-tumor necrosis factor-alpha drug levels are associated with improved radiological outcomes in patients with perianal fistulizing Crohn's disease: A retrospective multicenter study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 133 - 133, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200192&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'Is quality of bowel preparation affected by ambient temperature?', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 222 - 222, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200333&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'Using a novel patient decision aid to improve the quality of pregnancy-related shared decision making in inflammatory bowel disease: A pilot study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 143 - 143, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1